Back to results
US 2008/0306245 A1Published application
Method For The Production Of Albumen Conjugates With Non-Steroidal Antirheumatic Drugs (Nsar)
AssigneeAlbupharm Heidelberg GmbH & Co. KG
InventorsHannsjorg Sinn, Marcel Mulbaier
Life of this patent
Estimating the term…
Abstract
The present invention concerns NSAR (non-steroidal antirheumatic agents)-protein conjugates and in particular NSAR-albumin conjugates, processes for their production and their use as pharmaceutical preparations especially for treating inflammations.
Claims13
Use of an NSAR-albumin conjugate comprising a non-steroidal antirheumatic agent (NSAR) and albumin for producing a pharmaceutical agent to treat rheumatoid arthritis,
- characterized in that
- in the conjugate the NSAR is directly covalently bound to the albumin and the molar ratio of NSAR:albumin is in the range of about 2:1 to 0.1:1, wherein the conjugate is obtainable by reacting an NSAR and albumin in the presence of N-(3-dimethylamino-propyl)-N′-ethylcarbonyldiimide as the sole activation reagent in an organic solvent.
A process for the production of a conjugate comprising the reaction of an NSAR with albumin by direct covalent coupling,
- characterized in that
- an NSAR and albumin are reacted in the presence of N-(3-dimethylamino-propyl)-N′-ethylcarbonyldiimide as the sole activation reagent in an organic solvent,
- wherein the molar ratio of NSAR:human albumin is in the range of about 2:1 to 0.1:1.
Dependencies are inferred from the claim text.